BB Biotech Ventures is a Guernsey based healthcare venture capital firm focusing on investments in growth capital or earlier-stage technology platform companies. Its primary areas of investment include biotechnology, pharmaceutical, and medical devic...Show all
c/o Bellevue Asset Management AG
Seestrasse 16, Postfach
Kusnacht, 8700
Switzerland
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-02-01 | Moderna Therapeutics | Series G | $500M | Abu Dhabi Investment Authority, Alexandria Venture Investments, ArrowMark Partners, EDBI, Fidelity Investments, Julius Baer, Pictet Group, Sequoia Capital China, and Viking Global Investors |
| 2017-10-04 | Aleva Neurotherapeutics | Series D | $13M | Banexi Ventures, BioMedPartners, Forrestal Capital, Greatbatch, Initiative Capital Romandie, and Kinled Holding |
| 2017-01-23 | Atlas Genetics | Series D | $35M | Consort Medical, Guangzhou Wondfo Biotech, Johnson & Johnson Innovation, Life Sciences Partners, Novartis Venture Funds, RMI Partners, and Technology Venture Partners (UK) |
| 2016-12-06 | Abyrx | Series B | $10M | Canaan Partners, and MedEdge |
| 2016-05-27 | Aleva Neurotherapeutics | Series C | $18M | Banexi Ventures, BioMedPartners, Forrestal Capital, Greatbatch, Initiative Capital Romandie, and Kinled Holding |
